A new study shows that the stage of normal cell development at which B cells transform into leukemic cells impacts treatment ...

Cell therapies represent a promising frontier in modern medicine, offering potential to treat, and in some cases cure ...

Gallant’s stem cell therapies are aimed at tackling a painful mouth condition in cats and is on track for US FDA approval in ...

Ibrahim Aldoss, MD, discusses the potential of AZD0486 for treating relapsed or refractory B-cell acute lymphoblastic leukemia (ALL) and outlines the SYRUS study objectives.

Legislation that aims to prevent preventable deaths from tuberculosis infection is one step closer to becoming law.